Top 10 Companies in the Biocatalysts Market (2026): Market Leaders Driving Sustainable Innovation

In Business Insights
September 13, 2026


MARKET INTELLIGENCE OVERVIEW

Biocatalysts Market Insights

Biocatalysts are enzymes or whole‑cell systems employed to accelerate chemical transformations in industrial processes, providing greener, more sustainable alternatives to traditional chemical catalysis. Global biocatalysts market size was valued at USD 2,700 million in 2025. The market is projected to grow from USD 2,900 million in 2026 to USD 7,500 million by 2034, exhibiting a CAGR of 9.2% during the forecast period.

Biocatalysts Market – View in Detailed Research Report

📊
Current Market Size
2,700USD Mn

2025 Value

📈
CAGR
9.2%

2026–2034

🎯
Forecast Market Size
7,500USD Mn

By 2034

Strategic Market Outlook
Long‑Term Industry Perspective
Biocatalysts are gaining traction as industries prioritize sustainability; while enzyme engineering accelerates adoption, challenges such as high production costs and regulatory scrutiny persist. Furthermore, expanding applications in pharmaceuticals, fine chemicals, and food processing are driving demand worldwide.

🌐
Leading Region
North America

🌍
Emerging Region
Asia‑Pacific


🔟 1. Novozymes

Headquarters: Bagsværd, Denmark
Key Offering: High‑performance enzymes for pharma, fine chemicals, and biofuels

Novozymes leverages a proprietary protein‑engineering platform that consistently delivers enzymes with superior activity and stability. Its global manufacturing footprint and deep partnership network enable rapid scale‑up for customers across multiple sectors. The company’s commitment to decarbonising chemical processes is reflected in its investment in renewable feedstocks and carbon‑neutral production facilities.

Sustainability & Growth Initiatives:

  • Integrated R&D pipeline focused on green chemistry
  • Decarbonised manufacturing sites with renewable energy sourcing
  • Strategic alliances with leading chemical processors to embed enzymes in existing workflows

9️⃣ 2. DSM

Headquarters: Heerlen, Netherlands
Key Offering: Lipases, proteases, and oxidases for sustainable process solutions

DSM’s portfolio emphasizes enzymes that enable cleaner, energy‑efficient transformations. The company’s focus on circular bioeconomy principles is evident in its development of enzymes that convert agricultural residues into high‑value products.

Sustainability & Growth Initiatives:

  • Renewable feedstock utilisation in enzyme production
  • Process integration to reduce waste streams
  • Global network of customers in pharma, food, and fine chemicals

8️⃣ 3. BASF

Headquarters: Ludwigshafen, Germany
Key Offering: Customised enzyme blends for specialty chemical synthesis

BASF combines its core chemical expertise with biocatalysis to offer greener routes that cut solvent use and improve selectivity. The company’s robust supply chain and strong regulatory experience position it well for high‑value markets.

Sustainability & Growth Initiatives:

  • Green chemistry integration across product lines
  • Process safety enhancements through enzyme‑mediated steps
  • Global reach with localized production sites

7️⃣ 4. Johnson Matthey

Headquarters: London, United Kingdom
Key Offering: Metal‑free biocatalysts for pharmaceutical intermediates

Johnson Matthey capitalises on its long‑standing catalytic heritage to deliver enzymes that eliminate the need for metal catalysts, reducing both cost and environmental impact. The company’s focus on clean chemistry aligns with global regulatory trends.

Sustainability & Growth Initiatives:

  • Zero‑metal catalyst development to minimise waste
  • Regulatory‑compliant manufacturing processes
  • Partnerships with pharma leaders to embed enzymes early in drug development

6️⃣ 5. Lonza

Headquarters: Basel, Switzerland
Key Offering: High‑purity recombinant enzymes for clinical‑grade manufacturing

Lonza’s GMP‑certified production facilities support the delivery of enzymes that meet stringent quality standards required for biopharmaceutical production, enabling seamless integration into existing manufacturing pipelines.

Sustainability & Growth Initiatives:

  • GMP compliance to ensure product safety and consistency
  • Process optimisation to reduce energy consumption
  • Scalable fermentation platforms for rapid technology transfer

5️⃣ 6. Merck KGaA (MilliporeSigma)

Headquarters: Darmstadt, Germany
Key Offering: Analytical and preparative enzymes for research and scale‑up

Merck’s extensive catalogue supports both academic research and industrial scale‑up, providing a bridge between laboratory discovery and commercial production.

Sustainability & Growth Initiatives:

  • Research‑driven enzyme development pipeline
  • Process scale‑up solutions that minimise waste
  • Global distribution network to support diverse markets

4️⃣ 7. IFF

Headquarters: New York, United States
Key Offering: Enzymes for flavor, fragrance, and sustainable materials

Acquiring DuPont’s industrial biosciences assets, IFF has expanded its portfolio to include enzymes that drive the creation of eco‑friendly packaging and food‑grade products.

Sustainability & Growth Initiatives:

  • Development of biodegradable materials through enzyme catalysis
  • Flavor innovation to replace synthetic additives
  • Large‑scale production capacity for global demand

3️⃣ 8. Evolva

Headquarters: Basel, Switzerland
Key Offering: Directed evolution and computational design for specialty chemicals

Evolva’s platform accelerates the discovery of enzymes tailored to niche chemical routes, reducing the time and cost of bringing new biocatalysts to market.

Sustainability & Growth Initiatives:

  • Rapid prototyping of enzymes for high‑value applications
  • Use of renewable substrates in fermentation
  • Collaborations with industrial partners to validate new processes

2️⃣ 9. Codexis

Headquarters: Lexington, United States
Key Offering: Enzyme engineering for high‑value specialty applications

Codexis leverages advanced computational design to create enzymes that enable process intensification and reduce reliance on hazardous reagents.

Sustainability & Growth Initiatives:

  • Process intensification to lower energy footprints
  • Global network of partners to accelerate deployment
  • Investment in next‑generation enzyme platforms

1️⃣ 10. Lantheus

Headquarters: Boston, United States
Key Offering: Enzymes for diagnostics and therapeutic development

Lantheus focuses on high‑value, low‑waste enzyme solutions that support the creation of next‑generation diagnostics and biotherapeutics.

Sustainability & Growth Initiatives:

  • Diagnostic enzymes that reduce the need for synthetic reagents
  • Therapeutic platforms that minimise waste streams
  • Regulatory expertise to navigate complex approval pathways

Biocatalysts Market – View in Detailed Research Report

Biocatalysts Market – View in Detailed Research Report


Industry Outlook

The convergence of regulatory pressure for lower emissions and the rise of precision manufacturing has positioned biocatalysts as a cornerstone of next‑generation chemical production. Companies that embed enzymes early in the development cycle benefit from reduced capital intensity, faster time‑to‑market, and a demonstrable environmental advantage. The market is also witnessing a shift toward integrated bioprocessing, where enzyme‑based steps are combined with downstream purification to create fully sustainable production lines.

Future Trends

Key trends that will shape the biocatalysts landscape include:

  • Advances in directed evolution and machine‑learning‑driven design that unlock new substrate scopes.
  • Immobilisation technologies that enable continuous, high‑throughput processes.
  • Expansion into personalized medicine, where custom enzymes facilitate rapid synthesis of patient‑specific drugs.
  • Growth of industrial enzyme markets in textiles, detergents, and food, driven by consumer demand for clean‑label products.
  • Increased focus on circular bioeconomy, using agricultural residues and industrial by‑products as feedstocks for enzyme production.

Frequently Asked Questions

1. What is the current market size of the Biocatalysts Market?

The Biocatalysts Market was valued at USD 2,700 million in 2025 and is projected to reach USD 7,500 million by 2034, growing at a CAGR of 9.2% during the forecast period.

2. Which key companies operate in the Biocatalysts Market?

Key players include Novozymes, DSM, BASF, Johnson Matthey, Lonza, Merck KGaA (MilliporeSigma), IFF, Evolva, Codexis, and Lantheus.

3. What are the key growth drivers of the Biocatalysts Market?

Growing demand for sustainable biocatalytic processes, advances in enzyme engineering, and expanding applications in pharmaceuticals, fine chemicals, and food processing.

4. Which region dominates the market?

North America leads in current adoption, while the Asia‑Pacific region is experiencing rapid expansion driven by industrial growth and green chemistry initiatives.

5. What are the emerging trends in the Biocatalysts Market?

Advanced enzyme engineering, integration with continuous flow processes, and development of tailor‑made biocatalysts for specialty chemicals.